Clinical Trial Update: A Clinical Study to Investigate if a Single Dose of an Approved Drug Product (Glycopyrrolate Inhalation Solution) Reduces Trapped Air in the Lungs of Participants With Chronic Obstructive Pulmonary Disease. [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating whether a single dose of glycopyrrolate inhalation solution reduces trapped air in COPD patients; trial completed with results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Glycopyrrolate inhalation solution (glycopyrrolate)

Snippet

Sponsor: Sunovion Respiratory Development Inc. | Conditions: Chronic Obstructive Pulmonary Disease (COPD) | Phase 4 | Status: COMPLETED | Results posted: 2021-04-08